Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Sleep Disorders and Narcolepsy

The Sleep Disorders Channel is supported through educational grants from Takeda and Alkermes.

VJNeurology is an independent medical education platform. Channel supporters have no influence over the production of content.

View overview page
The alignment between subjective and objective measures in hypersomnolence disorders 2:59
The alignment between subjective and objective measures in hypersomnolence disorders
Lucie Barateau • 24 Jun 2026
Orexin agonists in narcolepsy: trial findings, subtype differences, and biomarker-guided therapy 3:45
Orexin agonists in narcolepsy: trial findings, subtype differences, and biomarker-guided therapy
Lucie Barateau • 24 Jun 2026
Improving the diagnosis of central disorders of hypersomnolence 2:09
Improving the diagnosis of central disorders of hypersomnolence
Nancy Foldvary-Schaefer • 19 Jun 2026
Individualized dosing of low-sodium oxybate for narcolepsy and idiopathic hypersomnia: DUET study 2:05
Individualized dosing of low-sodium oxybate for narcolepsy and idiopathic hypersomnia: DUET study
Nancy Foldvary-Schaefer • 19 Jun 2026
Evolving understanding of orexin deficiency in narcolepsy type 1 and the impact of orexin agonists 2:50
Evolving understanding of orexin deficiency in narcolepsy type 1 and the impact of orexin agonists
Nancy Foldvary-Schaefer • 19 Jun 2026
Data on oveporexton and alixorexton in narcolepsy presented at SLEEP 2026 2:52
Data on oveporexton and alixorexton in narcolepsy presented at SLEEP 2026
Nancy Foldvary-Schaefer • 19 Jun 2026
Managing narcolepsy during pregnancy: addressing critical evidence gaps 2:36
Managing narcolepsy during pregnancy: addressing critical evidence gaps
Kelsey Biddle • 16 Jun 2026
Wearable EEG shows promise for home diagnosis of central disorders of hypersomnolence 2:09
Wearable EEG shows promise for home diagnosis of central disorders of hypersomnolence
Dennis Hwang • 15 Jun 2026
Addressing disparities in narcolepsy and idiopathic hypersomnia care 2:05
Addressing disparities in narcolepsy and idiopathic hypersomnia care
Romy Hoque • 10 Jun 2026
Looking ahead to SLEEP 2026: highlights and key themes 3:09
Looking ahead to SLEEP 2026: highlights and key themes
Romy Hoque • 10 Jun 2026
AI and sleep biomarkers for predicting cardiovascular and neurologic disease 6:53
AI and sleep biomarkers for predicting cardiovascular and neurologic disease
Emmanuel Mignot • 30 Apr 2026
Orexin agonists and the future of narcolepsy treatment 7:00
Orexin agonists and the future of narcolepsy treatment
Emmanuel Mignot • 30 Apr 2026
Elevated influenza antibodies in recent-onset type-one narcolepsy 2:39
Elevated influenza antibodies in recent-onset type-one narcolepsy
Han Yan • 27 Apr 2026
The clinical potential of orexin-2 receptor agonists across sleep disorders 1:05
The clinical potential of orexin-2 receptor agonists across sleep disorders
Bruce Corser • 20 Apr 2026
Significant improvement in wakefulness with E2086 for narcolepsy: findings from a Phase I trial 2:08
Significant improvement in wakefulness with E2086 for narcolepsy: findings from a Phase I trial
Bruce Corser • 20 Apr 2026
Sleep highlights from EAN 2025: brain health and orexin agonists 2:23
Sleep highlights from EAN 2025: brain health and orexin agonists
Ambra Stefani • 23 Jun 2025

The Sleep Disorders Channel is supported through educational grants from Takeda and Alkermes.

VJNeurology is an independent medical education platform. Channel supporters have no influence over the production of content.

If you are interested in becoming a supporter of The Sleep Disorders Channel, please contact us.

The content of VJNeurology is intended for healthcare professionals